H.R. 7407

Summary

H.R. 7407, the Prohibiting Tianeptine and Other Dangerous Products Act of 2026, was introduced in the House on Feb 5, 2026 by Rep. Frank Pallone (D). It was referred to Energy And Commerce, and last saw action on Feb 5, 2026: Referred to the House Committee on Energy and Commerce.

Record

Text

H.R. 7407 has no co-sponsors and has not gone to a roll call.

119 HR 7407 IH: Prohibiting Tianeptine and Other Dangerous Products Act of 2026
 U.S. House of Representatives
 2026-02-05
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  2d Session  H. R. 7407  IN THE HOUSE OF REPRESENTATIVES   February 5, 2026   Mr. Pallone  introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.
1.
Short title
This Act may be cited as the   Prohibiting Tianeptine and Other Dangerous Products Act of 2026  .
2.
New prohibited acts relating to dietary supplements
(a)
In general
Section 301 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 331 ) is amended by adding at the end the following:
(jjj)
The introduction or delivery for introduction into interstate commerce of any product marketed as a dietary supplement that does not meet the definition of a dietary supplement under section 201(ff).
(kkk)
The introduction or delivery for introduction into interstate commerce of a dietary supplement that has been prepared, packed, or held using the assistance of, or at the direction of, a person debarred under section 306.
 .
(b)
New import exclusion
Section 801(a) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 381(a) ) is amended in paragraph (3) of the third sentence, by striking  section 301(ll)  and inserting  paragraph (ll), (jjj), or (kkk) of section 301 .
(c)
New seizure authorities
Section 304 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 334 ) is amended—
(1)
in subsection (a)(1), in the first sentence, by striking  section section 301(ll), 404, or 505  and inserting  paragraph (ll), (jjj), or (kkk) of section 301, section 404, or section 505 ; and
(2)
in subsection (d)(1), in the first sentence, by inserting  , or product in violation of paragraph (jjj) or (kkk) of section 301,  after  condemned under this section .

Tracker

The tracker indicates the progress of this legislation as it moves through the legislative process.

To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements.

Sponsors

Rep. Frank Pallone (D) sponsors H.R. 7407 alone.

Frank Pallone

Rep. · D–NJ-6 · Sponsor

Show 1 of 1 row

PreviousNext

Committees

H.R. 7407 went before 1 committee: Energy and Commerce.

Energy and Commerce

Energy and Commerce

Referred To · Feb 5, 2026 · 1,636 Bills

Actions

H.R. 7407 has taken 2 actions since Feb 5, 2026.

Votes

H.R. 7407 has not gone to a roll call.

Related bills

1 bill is related to H.R. 7407, as Identical bill.

S 3797Prohibiting Tianeptine and Other Dangerous Products Act of 2026Feb 5, 2026 · Read twice and referred to the Committee on Health, Education, Labor, and Pensi… · Identical bill

Show 1 of 1 row

PreviousNext

Titles

H.R. 7407 goes by 3 titles, 1 of them short titles.

• Prohibiting Tianeptine and Other Dangerous Products Act of 2026 — Display Title
• Prohibiting Tianeptine and Other Dangerous Products Act of 2026 — Short Title(s) as Introduced
• To amend the Federal Food, Drug, and Cosmetic Act to establish new prohibited acts relating to dietary supplements. — Official Title as Introduced

Lobbying

1 client hired 1 firm and 2 registered lobbyists who named H.R. 7407 in 1 quarterly filing, 2026. Reported under the Lobbying Disclosure Act; a filing’s income covers everything its registrant worked that quarter, so the amounts below are the filings’, not this bill’s.

Filed under Food Industry (safety, labeling, etc.), Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code.

Clients

Who paid to be heard, by how many filings named the bill.

Firms

Registrants who filed on the bill, by filings.

Lobbyists

Named on the filings that cite the bill.

Filings

The documents themselves, on the Senate’s Lobbying Disclosure site, largest reported first.

Classification

The Congressional Research Service files H.R. 7407 under Health, one of its 31 policy areas.

CRS Subjects

CRS assigns every bill one policy area from its 31; H.R. 7407’s is Health.

Constitutional authority

The clause the sponsor cites as Congress’s power to enact H.R. 7407, as entered in the Congressional Record.

[Congressional Record Volume 172, Number 26 (Thursday, February 5, 2026)][House][Pages H2041-H2042]From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]By Mr. PALLONE:H.R. 7407.[[Page H2042]]Congress has the power to enact this legislation pursuantto the following:Under Article I, Section 8, Clause 3: [The Congress shallhave Power] To regulate Commerce with foreign Nations, andamong the several States, and with the Indian Tribes

Source: congress.gov · legiscan.com